Literature DB >> 25336865

Pyrazinamide-induced hyperuricemia.

Antony Q Pham, Anh Doan, Matt Andersen.   

Abstract

Elevated uric acid levels can cause crystal deposition and may lead to gout, urolithiasis, and urate nephropathy. The authors report on the case of a 34-year-old male whose hyperuricemia was associated with the antituberculous drug pyrazinamide.

Entities:  

Year:  2014        PMID： 25336865      PMCID： PMC4189695     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  11 in total

Review 1.  Drug-induced gout.

Authors:  J T Scott
Journal:  Baillieres Clin Rheumatol       Date:  1991-04

Review 2.  Therapeutic perspectives on uricases for gout.

Authors:  Ricardo P Garay; M Raafat El-Gewely; Jean-Pierre Labaune; Pascal Richette
Journal:  Joint Bone Spine       Date:  2012-02-25       Impact factor: 4.929

3.  Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.

Authors:  Gokhan Tumgor; Cigdem Arikan; Murat Kilic; Sema Aydogdu
Journal:  Pediatr Transplant       Date:  2006-09

4.  Hyperuricemia due to ethambutol.

Authors:  A E Postlethwaite; A G Bartel; W N Kelley
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

5.  Renal function in gout. 3. Estimation of tubular secretion and reabsorption of uric acid by use of pyrazinamide (pyrazinoic acid).

Authors:  A B Gutman; T F Yü; L Berger
Journal:  Am J Med       Date:  1969-10       Impact factor: 4.965

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 7.  Gout and hyperuricemia.

Authors:  M D Harris; L B Siegel; J A Alloway
Journal:  Am Fam Physician       Date:  1999-02-15       Impact factor: 3.292

8.  Paradoxical increase in uric acid level with allopurinol use in pyrazinamide-induced hyperuricaemia.

Authors:  Vedat Gerdan; Nurullah Akkoc; Eyup Sabri Ucan; Serpil Bulac Kir
Journal:  Singapore Med J       Date:  2013-06       Impact factor: 1.858

9.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

Review 10.  The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.

Authors:  David Gustafsson; Robert Unwin
Journal:  BMC Nephrol       Date:  2013-07-29       Impact factor: 2.388
View more
  3 in total

1.  Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study.

Authors:  Arif I Dela; Nitish Kumar D Tank; Anil P Singh; Kiran G Piparva
Journal:  Lung India       Date:  2017 Nov-Dec

2.  Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: A retrospective study.

Authors:  Tae Won Yang; Hyun Oh Park; Ha Nee Jang; Jun Ho Yang; Sung Hwan Kim; Seong Ho Moon; Joung Hun Byun; Chung Eun Lee; Jong Woo Kim; Dong Hun Kang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 3.  Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout.

Authors:  Fernando Pérez-Ruiz; Tim Jansen; Anne-Katrin Tausche; Mónica Juárez-Campo; Ravichandra Karra Gurunath; Pascal Richette
Journal:  Drugs Context       Date:  2019-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.